InvestorsHub Logo
Followers 125
Posts 20384
Boards Moderated 1
Alias Born 12/09/2004

Re: None

Tuesday, 10/27/2020 4:04:40 PM

Tuesday, October 27, 2020 4:04:40 PM

Post# of 42557
HGEN Presentation tomorrow:
Humanigen, Inc., (Nasdaq: HGEN) ("Humanigen"), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm' with its lead drug candidate lenzilumab(TM), today announced that the Company's management will present or participate in panel discussions at the following upcoming virtual investor conferences:



This seems very last second. Do we finally have something to say? I am guessing we see a PR tomorrow morning!